Skip to Content

Recombivax HB Dialysis Formulation (hepatitis b adult vaccine) Disease Interactions

There is 1 disease interaction with Recombivax HB Dialysis Formulation (hepatitis b adult vaccine):


Hepatitis B vaccine (Includes Recombivax HB Dialysis Formulation) ↔ hemophilia

Moderate Potential Hazard, Moderate plausibility. Applies to: Bleeding Associated with Coagulation Defect

Hepatitis B vaccine (adult and pediatric) is usually for intramuscular administration. However, it may be administered subcutaneously to persons at risk for hemorrhage following intramuscular injections (e.g., hemophiliacs), although it may result in lower antibody response. Additionally, when other aluminum- absorbed vaccines have been administered subcutaneously, an increased incidence of local reactions including subcutaneous nodules has been observed. Therefore, consider subcutaneous administration only in persons who are at risk of hemorrhage following intramuscular injections.

Recombivax HB Dialysis Formulation (hepatitis b adult vaccine) drug interactions

There are 202 drug interactions with Recombivax HB Dialysis Formulation (hepatitis b adult vaccine)

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.